Evidence map›Paper›PMID 24719290›Full record

ArticleChembiochem : a European journal of chemical biology2014

Cellular scent of influenza virus infection.

Alexander A Aksenov, Christian E Sandrock, Weixiang Zhao, Shankar Sankaran, Michael Schivo, Richart Harper, Carol J Cardona, Zheng Xing, Cristina E Davis

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Tuning phosphorene and MoSRSC advances · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Breath Biomarkers of Influenza Infection.Open forum infectious diseases · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Alexander A AksenovDepartment of Mechanical and Aeronautical Engineering, University of California, Davis, One Shields Ave, Davis, CA 95616 (USA).
Christian E Sandrock
Weixiang Zhao
Shankar Sankaran
Michael Schivo
Richart Harper
Carol J Cardona
Zheng Xing
Cristina E Davis
University of California, Davis · USUniversity of California Davis Medical Center · USUniversity of Minnesota · US

Funding

UC Davis Clinical and Translational Science CenterUL1TR000002 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2012 to 2015
$12.2M
TRAINING IN COMPARATIVE LUNG BIOLOGY AND MEDICINET32HL007013 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI Elena Goncharova, Nicholas J. KENYON · 1985 to 2026
$10.1M
ENVIRONMENTAL TOXICOLOGYT32ES007059 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura S Van Winkle · 1985 to 2026
$7.9M
UC Davis Clinical and Translational Science CenterKL2TR000134 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2012 to 2015
$3.1M
Minority Short-Term Training in Environmental ToxicologyT35ES007301 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI MILLER, MARION · 1995 to 2009
$298k
NCATS NIH HHS 8KL2TR000134-07K12NCATS NIH HHS KL2 TR000134NCATS NIH HHS UL1 TR000002NHLBI NIH HHS T32 HL007013NHLBI NIH HHS T32-HL007013NIEHS NIH HHS T32 ES007059NIEHS NIH HHS T32-ES007059NIEHS NIH HHS T35 ES007301
6 · The paper itself

Abstract

Volatile organic compounds (VOCs) emanating from humans have the potential to revolutionize non-invasive diagnostics. Yet, little is known about how these compounds are generated by complex biological systems, and even less is known about how these compounds are reflective of a particular physiological state. In this proof-of-concept study, we examined VOCs produced directly at the cellular level from B lymphoblastoid cells upon infection with three live influenza virus subtypes: H9N2 (avian), H6N2 (avian), and H1N1 (human). Using a single cell line helped to alleviate some of the complexity and variability when studying VOC production by an entire organism, and it allowed us to discern marked differences in VOC production upon infection of the cells. The patterns of VOCs produced in response to infection were unique for each virus subtype, while several other non-specific VOCs were produced after infections with all three strains. Also, there was a specific time course of VOC release post infection. Among emitted VOCs, production of esters and other oxygenated compounds was particularly notable, and these may be attributed to increased oxidative stress resulting from infection. Elucidating VOC signatures that result from the host cells response to infection may yield an avenue for non-invasive diagnostics and therapy of influenza and other viral infections.

Indexed as

BiomarkersB-LymphocytesCell LineGas Chromatography-Mass SpectrometryHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H9N2 SubtypeInfluenza, HumanVolatile Organic CompoundsBiomarkersVolatile Organic Compoundsbreath analysisestersgas chromatographyinfluenzamass spectrometryvolatile organic compounds

Identifiers

PMID24719290
PMCPMC4104277
OpenAlexW2139673600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.